ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
37 hedge funds and large institutions have $765M invested in Orchard Therapeutics plc American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.11%
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$321M |
2 |
DM
Deerfield Management
New York
|
+$126M |
3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$76.2M |
4 |
CI
Cowen Inc
New York
|
+$46.1M |
5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$30.1M |
Top Sellers
No sellers this quarter